Xencor (XNCR) Net Margin (2013 - 2026)

Xencor's (XNCR) quarterly Net Margin came in at 2855.09% in Q1 2026, down 270642.0% year-on-year from N/an in Q1 2025, and down 12017.73% on a QoQ basis from 23.56% in Q4 2025.

Xencor (XNCR) Net Margin (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Net Margin data on file, last reported at 2855.09% in Q1 2026.

  • On a quarterly basis, Net Margin fell 270642.0% year-over-year to 2855.09% in Q1 2026; TTM through Mar 2026 was 177.12%, a 1120.0% decrease from a year earlier, with the FY2025 full-year figure at 73.37%, up 14071.0% from the prior year.
  • Net Margin for Q1 2026 stood at 2855.09%, down from 23.56% in the prior quarter.
  • Over the last five years, Net Margin for XNCR reached as high as 27.6% in Q1 2022 and fell as low as 2855.09% in Q1 2026.
  • Historically, Net Margin has averaged 297.03% across 5 years, with a median of 112.5% in 2022.
  • Across the five-year window, Net Margin soared 31463 bps in 2025 and tumbled 270642 bps in 2026, its largest moves.
  • Year by year, Net Margin stood at 55.72% in 2022, then rose by 7 bps to 51.57% in 2023, then slumped by 70 bps to 87.51% in 2024, then surged by 73 bps to 23.56% in 2025, then sank by 12018 bps to 2855.09% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 2855.09% in Q1 2026, 23.56% in Q4 2025, and 28.7% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Xencor 1.47 Bn 1.09 Bn - -2,855.09%

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,855.09%
Dec 31, 2025 -23.56%
Sep 30, 2025 -28.70%
Jun 30, 2025 -70.69%
Mar 31, 2025 -148.68%
Dec 31, 2024 -87.51%
Sep 30, 2024 -266.59%
Jun 30, 2024 -287.71%
Mar 31, 2024 -463.31%
Dec 31, 2023 -51.57%
Sep 30, 2023 -40.99%
Jun 30, 2023 -156.28%
Mar 31, 2023 -308.26%
Dec 31, 2022 -55.72%
Sep 30, 2022 -120.00%
Jun 30, 2022 -112.50%
Mar 31, 2022 27.60%
Dec 31, 2021 47.44%
Sep 30, 2021 -204.19%
Jun 30, 2021 77.47%